Viewing Study NCT04757259


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-01-31 @ 10:49 AM
Study NCT ID: NCT04757259
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-03-19
First Post: 2021-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Program for Participants Who Completed Study 13-601 and Continue to Clinically Benefit From Cerdulatinib
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module